Targazyme
Chair of the Cardiovascular Biology Research Program, Merrick Foundation Chair in Biomedical Research. Adjunct Professor in the Department of Biochemistry and Molecular Biology at the University of Oklahoma Health Sciences Center. He received his MD at Binzhou Medical College (China) in 1982 and graduated with his Ph.D. from Soochow University Medical College (China) in 1995. He joined the Oklahoma Medical Research Foundation in 2002. His work has focused on a group of sugars known as O-glycans, yielding important information about liver disease, cancer and other illnesses.
This person is not in the org chart
This person is not in any offices
Targazyme
Targazyme Inc. is a San Diego-based, clinical-stage biopharmaceutical company developing novel enzyme-based platform technologies and products to improve clinical efficacy and cost of care outcomes for cell therapy, immunotherapies for autoimmune diseases and cancer, stem cell transplantation, gene therapy and regenerative medicine.